Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
How does blood glucose control with insulin save lives in intensive care?
Greet Van den Berghe
Greet Van den Berghe
Published November 1, 2004
Citation Information: J Clin Invest. 2004;114(9):1187-1195. https://doi.org/10.1172/JCI23506.
View: Text | PDF
Science in Medicine

How does blood glucose control with insulin save lives in intensive care?

  • Text
  • PDF
Abstract

Patients requiring prolonged intensive care are at high risk for multiple organ failure and death. Insulin resistance and hyperglycemia accompany critical illness, and the severity of this “diabetes of stress” reflects the risk of death. Recently it was shown that preventing hyperglycemia with insulin substantially improves outcome of critical illness. This article examines some potential mechanisms underlying prevention of glucose toxicity as well as the effects of insulin independent of glucose control. Unraveling the molecular mechanisms will provide new insights into the pathogenesis of multiple organ failure and open avenues for novel therapeutic strategies.

Authors

Greet Van den Berghe

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Intensive insulin therapy saves lives in the intensive care unit. Kaplan...
Intensive insulin therapy saves lives in the intensive care unit. Kaplan-Meier curves show cumulative survival of 1,548 patients from the Leuven study who received intensive insulin treatment (blood glucose maintained below 110 mg/dl; yellow) or conventional insulin treatment (insulin only given when blood glucose exceeded 200 mg/dl, resulting in mean blood glucose levels of 150–160 mg/dl; green) during their ICU or hospital stay. The upper panels display results from all patients; the lower panels display results for long-stay (>5 days) ICU patients only. P values were determined with the use of the Mantel-Cox log-rank test. Adapted with permission from the New England Journal of Medicine (10).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts